Terms

Terms of use.

Released: · Last reviewed:

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

Terms of use.

Use of this site

Information here is published for general use and provided as-is. It is not medical advice and does not create a clinician relationship. Prices change; verify with the provider before purchasing.

Accuracy and liability

Every figure carries a capture date and an evidence status. We correct errors when they are reported and log them publicly, but we cannot guarantee that a price is current at the moment you read it, which is why every programme page links to that programme's own pricing page.

How this site works

Every price on this site is read on the program’s own pages and carries its read date. Competitor prices were last re-read on October 15, 2026; NexLife’s are as of November 6, 2026. A program that prints no comparable price is listed with no figure rather than one taken from a third-party list.

Tirzepatide Telehealth Comparison is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report. NexLife is our editorial pick on the v4.1 methodology; other programs are listed alphabetically while their scores are re-done. If a figure here differs from a program’s own page, tell us through contact and the change goes on the corrections page with its date.

Primary sources

Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.

  1. FDA — Human Drug Compounding
  2. FDA — Compounding and the FDA: Questions and Answers
  3. FTC — Health Products Compliance Guidance
  4. FTC — Endorsement and testimonial guidance
  5. NABP — State Boards of Pharmacy directory